Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 14/20 | 0.75 |
| ▸ | JAK2 | O60674 | 13/20 | 0.75 |
| ▸ | JAK3 | P52333 | 15/20 | 0.60 |
| ▸ | TYK2 | P29597 | 10/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GBA1 | P04062 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | AURKA | O14965 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12385291 | 0.86 | JAK1 (0.82) | JAK1JAK2JAK3TYK2AURKA | |
| SCHEMBL2225210 | 0.86 | JAK2 (1.00) | JAK1JAK2JAK3TYK2AURKA | |
| SCHEMBL2277822 | 0.83 | JAK2 (0.70) | JAK1JAK2JAK3TYK2AURKA | |
| SCHEMBL12385383 | 0.81 | JAK1 (0.58) | JAK1JAK2JAK3TYK2AURKA | |
| SCHEMBL2295228 | 0.81 | JAK1 (0.65) | JAK1JAK2JAK3TYK2 | |
| SCHEMBL2274296 | 0.81 | JAK1 (0.76) | JAK1JAK2JAK3TYK2 | |
| SCHEMBL12385332 | 0.81 | JAK1 (0.76) | JAK1JAK2JAK3TYK2AURKA | |
| SCHEMBL2296561 | 0.81 | JAK1 (0.62) | JAK1JAK2JAK3TYK2 | |
| SCHEMBL12385225 | 0.80 | JAK1 (0.78) | JAK1JAK2JAK3TYK2 | |
| SCHEMBL12385315 | 0.80 | JAK1 (0.75) | JAK1JAK2JAK3TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |